Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty
Elancheleyen Mahindran, Jia Xian Law, Min Hwei Ng, Fazlina Nordin
International Journal of Molecular Sciences · 2021 · ▲ 20 citations
Abstract
Projected life expectancy continues to grow worldwide owing to the advancement of new treatments and technologies leading to rapid growth of geriatric population. Thus, age-associated diseases especially in the musculoskeletal system are becoming more common. Loss of bone (osteoporosis) and muscle (sarcopenia) mass are conditions whose prevalence is increasing because of the change in population distribution in the world towards an older mean age. The deterioration in the bone and muscle functions can cause severe disability and seriously affects the patients' quality of life. Currently, there is no treatment to prevent and reverse age-related musculoskeletal frailty. Existing interventions are mainly to slow down and control the signs and symptoms. Mesenchymal stem cell (MSC) transplantation is a promising approach to attenuate age-related musculoskeletal frailty. This review compiles the present knowledge of the causes and changes of the musculoskeletal frailty and the potential of MSC transplantation as a regenerative therapy for age-related musculoskeletal frailty.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms221910542
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Mahindran, E., Law, J.X., Ng, M.H., & Nordin, F. (2021). Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms221910542
Vancouver
Mahindran E, Law JX, Ng MH, Nordin F. Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms221910542.
BibTeX
@article{elancheleyen2021Mesenc,
title = {Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty},
author = {Elancheleyen Mahindran and Jia Xian Law and Min Hwei Ng and Fazlina Nordin},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms221910542},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomolecules 2023
Open access · CC-BY
Potential and Limitations of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells in Musculoskeletal Disorders Treatment
University Department of Geriatric Medicine FELIX PLATTER 2024
Open access · US-GOV
Comparison of Artificial Intelligence-based Analysis of Computed Tomography Data With Routinely Performed Measurements Concerning Bone and Muscle Health of Aged Individuals to Validate Surrogate Parameters for the Aging Population.
Gerontology 2017
Citation only
Regenerative Medicine Approaches for Age-Related Muscle Loss and Sarcopenia: A Mini-Review
VA Office of Research and Development 2015
Open access · US-GOV
Testosterone Replacement to Augment Lifestyle Therapy in Obese Older Veterans
InTech eBooks 2017
Open access · CC-BY
Allogeneic Mesenchymal Stem Cells as a Treatment for Aging Frailty
Advanced Therapeutics 2024
Open access · OA